Results 191 to 200 of about 182,632 (352)
A method to assess compositional bias in biological sequences and its application to prion-like glutamine/asparagine-rich domains in eukaryotic proteomes [PDF]
Paul M. Harrison, Mark Gerstein
openalex +1 more source
Asparagine Endopeptidase (δ Secretase), an Enzyme Implicated in Alzheimer’s Disease Pathology, Is an Inhibitor of Axon Regeneration in Peripheral Nerves [PDF]
Arthur W. English +4 more
openalex +1 more source
Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley +1 more source
Marine-derived L-asparaginase: unlocking marine power in anti-tumor therapeutics. [PDF]
Gopalakrishnan R +5 more
europepmc +1 more source
Abstract Background Plasma amino acid (AA) profiles in parenteral nutrition (PN)–dependent very preterm infants (VPIs) consistently show overprovision of essential AA (EAA) and arginine deficiency. This may have implications for growth and immune/inflammatory responses.
Frances Callaghan +6 more
wiley +1 more source
Targeting distinct amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas. [PDF]
Ohba S +12 more
europepmc +1 more source
An REMD and QM/MM study into the sequence effect on asparagine deamidation [PDF]
Catak, Saron +6 more
core +1 more source
New pyrido[2,3‐d]azolopyrimidinones were synthesized and evaluated as potent EGFR‐targeted anticancer leads. Molecular docking and cytotoxicity studies revealed strong receptor binding and submicromolar activity, highlighting this scaffold as a promising framework for future targeted drug development.
Sobhi M. Gomha +6 more
wiley +1 more source

